With respect to body weight, a higher baseline body-mass-index is a predictor of absolute weight reduction, albeit with substantial body weight loss even in those with a BMI 50 years with either chronic kidney disease and an eGFR of less than 60 ml/min per 1.73 m 2 or history of congestive heart failure (NY Heart Association Class II or III)
Safety and tolerability of once-weekly GLP-1 receptor agonists in type 2 diabetes
In the OASIS-1 study, 13% of participants (people with obesity without diabetes) receiving oral semaglutide 50 mg experienced altered skin sensation events compared to 1% with placebo - these events were generally mild to moderate in severity, occurred during dose escalation to the higher doses and resolved without requiring permanent treatment discontinuation [21]
Zheng J, Shi Y, Xiong L, Zhang W, Li Y, Gibson PG, et al
You may now have picked up some clues as to glutathiones benefits, but this compound really fulfillls many roles in the body
J.et al (2013)